Trademark: 88451927
Word
EMINDES CANCER ONCOLOGICAL IMMUNOTHERAPY
Status Date
Tuesday, December 17, 2019
Registration Number
5937116
Registration Date
Tuesday, December 17, 2019
Filing Date
Thursday, May 30, 2019
Published for Opposition
Tuesday, October 1, 2019
44 Medical services; Medical services in the field of oncological immunotherapy
The colors light blue, blue, white and dark gray are claimed as a feature of the mark.
"CANCER" AND "ONCOLOGICAL IMMUNOTHERAPY"
The mark consists of a stylized light blue and blue orb with a stylized light blue tree on it, white shading on the top right portion, the orb being contained within two stylized blue leaves. To the right of the orb is the upper case blue wording "EMINDES CANCER," underneath which is the title case dark gray wording "ONCOLOGICAL IMMUNOTHERAPY."
Dec 17, 2019
Registered-Principal Register
Oct 1, 2019
Official Gazette Publication Confirmation E-Mailed
Oct 1, 2019
Published For Opposition
Sep 11, 2019
Notification Of Notice Of Publication E-Mailed
Aug 29, 2019
Assigned To Lie
Aug 21, 2019
Approved For Pub - Principal Register
Aug 21, 2019
Examiner's Amendment Entered
Aug 21, 2019
Notification Of Examiners Amendment E-Mailed
Aug 21, 2019
Examiners Amendment E-Mailed
Aug 21, 2019
Examiners Amendment -Written
Aug 21, 2019
Assigned To Examiner
Jun 14, 2019
Notice Of Design Search Code E-Mailed
Jun 13, 2019
New Application Office Supplied Data Entered In Tram
Jun 3, 2019
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
